Almirall S.A. is introducing Act4Impact 2030, a new sustainability strategy.
The strategy focuses on five pillars: Planet, People, Patients, Partners, and Principles.
Act4Impact consists of 20 strategic lines of action which will be monitored over time to assess progress. These include the deployment of its Net Zero Roadmap through energy decarbonization, sustainable mobility or supplier engagement plan, as well as the definition and deployment of the 2030 Global Diversity, Equity, and Inclusion Plan, including all types of diversity, or the enhancement of our Supplier Risk Management Process.
Within the Planet pillar, Almirall is committed to taking decisive climate action to become a net-zero emissions company by 2050. A near-term milestone is the reduction of emissions by 50% from its own operations and by 28% from its value chain by 2030. Initiatives to achieve these goals include energy decarbonization, sustainable mobility. and sustainable procurement practices as well as water stewardship, circular economy principles, and nature preservation which are aimed at reducing water usage and waste-to-landfill in the short term.
Through the People pillar, Almirall will implement a dedicated program for Diversity, Equity, and Inclusion, accelerating the achievement of its equity-related targets, such as the gender pay gap, and measures of employee perceptions of diversity, equity, and inclusion. Almirall is alos reinforcing its corporate wellbeing initiatives, and will launch a new social action and volunteering program.
The patient pillar is focused on continued engagement with patient organizations, and by further embedding a patient-centric mindset across the organization. The overarching goal is to positively impact over 1.8 million people through Almirall’s dermatology portfolio by 2030.
Through the “Partners” strategy pillar, Almirall aims for a minimum reduction in CO2 emissions of 69% among suppliers with a carbon scorecard by 2030. The company will roll out sustainable procurement programs and engage suppliers in its Net Zero Supplier Engagement initiative.
The Principles pillar involves sustainability training to all employees by 2030 and will gauge employee perceptions on the company culture.
Recently, Almirall was rated as one of the top 5% of companies in the pharmaceutical industry by Sustainalytics. The CDP (Carbon Disclosure Project) awarded Almirall an outstanding “A-, Leadership” score in Climate Change and a “B, Management” score in Water Security. Ecovadis recognized Almirall with a platinum medal, placing it in the top 1% of evaluated pharmaceutical companies for sustainability.
